Glycolytic heterogeneity drives metabolic-targeted therapy in pancreatic ductal adenocarcinoma.

Signal Transduct Target Ther · 2026 · PMC12816621 · PMID 41554705

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Enrichment analyses revealed a trend toward EMT suppression, although this reduction did not reach statistical significance (Supplementary Fig. 12a ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.